Amiot Aurelien, Joly Francisca, Alves Arnaud, Panis Yves, Bouhnik Yoram, Messing Bernard
Pôle des maladies de l'appareil digestif, Service de gastroentérologie et d'assistance nutritive, Université Paris 7, AP-HP, Hôpital Beaujon, Clichy, France.
Am J Gastroenterol. 2009 May;104(5):1262-70. doi: 10.1038/ajg.2009.58. Epub 2009 Apr 14.
Chronic intestinal pseudo-obstruction (CIPO) is a rare, disabling disorder responsible for motility-related intestinal failure. Because it induces malnutrition, CIPO is a significant indication for home parenteral nutrition (HPN). The objective of the study was to evaluate long-term outcome of CIPO patients requiring HPN during adulthood.
In total, 51 adult CIPO patients (18 men/33 women, median age at symptom occurrence 20 (0-74) years, 34/17 primary/secondary CIPO) followed up at our institution for HPN management between 1980 and 2006 were retrospectively studied for survival and HPN dependence rates using univariate and multivariate analysis.
Follow-up after diagnosis was 8.3 (0-29) years. Surgery was required in 84% of patients. The number of interventions was 3 +/- 3 per patient (mean +/- s.d.), leading to short bowel syndrome in 19 (37%) patients. Actuarial survival probability was 94, 78, 75, and 68% at 1, 5, 10, and 15 years, respectively. Multivariate analysis showed that lower mortality was associated with the ability to restore oral feeding at baseline (hazard ratio (HR) = 0.2 (0.06-0.65), P = 0.008) and symptom occurrence before the age of 20 years (HR=0.18 (0.04-0.88), P = 0.03). Higher mortality was associated with systemic sclerosis (HR=10.4 (1.6-67.9), P = 0.01). Actuarial HPN dependence was 94, 75, and 72% at 1, 2, and 5 years, respectively.
In this large cohort of CIPO adult patients with severe intestinal failure, i.e., those requiring HPN, we found a higher survival probability than previously reported. These results should be taken into account when considering intestinal transplantation.
慢性肠道假性梗阻(CIPO)是一种罕见的、导致功能障碍的疾病,可引起与动力相关的肠道衰竭。由于它会导致营养不良,CIPO是家庭肠外营养(HPN)的重要指征。本研究的目的是评估成年期需要HPN的CIPO患者的长期预后。
回顾性研究了1980年至2006年间在我们机构接受HPN管理随访的51例成年CIPO患者(18例男性/33例女性,症状出现时的中位年龄为20(0-74)岁,34/17例为原发性/继发性CIPO),采用单因素和多因素分析评估生存率和HPN依赖率。
诊断后的随访时间为8.3(0-29)年。84%的患者需要手术。每位患者的干预次数为3±3次(均值±标准差),19例(37%)患者出现短肠综合征。1年、5年、10年和15年的精算生存概率分别为94%、78%、75%和68%。多因素分析显示,较低的死亡率与基线时恢复经口喂养的能力相关(风险比(HR)=0.2(0.06-0.65),P=0.008)以及20岁之前出现症状相关(HR=0.18(0.04-0.88),P=0.03)。较高的死亡率与系统性硬化症相关(HR=10.4(1.6-67.9),P=0.01)。1年、2年和5年的精算HPN依赖率分别为94%、75%和72%。
在这一大量需要HPN的严重肠道衰竭的成年CIPO患者队列中,我们发现生存率高于先前报道。在考虑肠道移植时应考虑这些结果。